Clinical Trials Directory

Trials / Completed

CompletedNCT02624011

Influence of Sedentary Time on Skeletal Muscle Protein Metabolism

Influence of Increased Sedentary Time on Long-term Rates of Skeletal Muscle Protein Synthesis in Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
University of Birmingham · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study will investigate the influence of increased sedentary time on long-term measures of muscle protein synthesis and metabolic health. The investigators will test the hypothesis that increased time spent in sedentary behaviours will lead to a reduction in long-term measures of muscle protein synthesis and compromised metabolic health.

Detailed description

Sarcopenia, the loss of muscle mass with age, is thought to be accelerated by an inactive, sedentary lifestyle. Increased sedentary time has consistently been associated with lower muscle mass and compromised metabolic health. However, there is currently a lack of direct evidence to support these associations. Therefore, this study will investigate whether increased sedentary time (reduced step count and exercise cessation) directly influences long-term measures of muscle protein synthesis and metabolic health in young, active adults. Following a 7 day period of normal habitual physical activity, participants will undertake a 7 day period of step reduction and exercise cessation. It is hypothesised that 7 days of increased sedentary time will result in a reduction in long-term rates of muscle protein synthesis and a worsening of metabolic health.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL7 days of habitual physical activity followed by 7 days of reduced physical activityYoung, active participants will undergo a 7 day period of habitual physical activity followed by a 7 day period of step reduction and exercise cessation.

Timeline

Start date
2016-03-01
Primary completion
2017-04-01
Completion
2018-02-01
First posted
2015-12-08
Last updated
2018-10-11

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02624011. Inclusion in this directory is not an endorsement.